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Background: It was previously found, in a pilot study, that Word Reading Threshold (WRT) test is abnormally
prolonged in individuals with Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI), with high sensitivity
and specificity. This validation study examines the WRT test as a prognostic tool in MCI individuals. We wish to
confirm in a larger group the sensitivity and specificity of the WRT test and determine whether it is influenced by
deterioration on other cognitive domains.
Methods: We measured WRT in 60 MCI individuals, 29 AD patients, and 33 normal elderly control (NE). We
followed the MCI individuals over 8 years to monitor who progressed to dementia.
Results: We found a statistically significant difference in WRT scores between the three groups. However, using the
same cutoff of 85 milliseconds suggested by Massoud and his colleagues, we found lower diagnostic sensitivity
(72%) and specificity (76%) when comparing NC and AD. Furthermore, the test did not clearly differentiate MCI
individuals who progressed to dementia from those who did not. WRT was found to correlate to some degree with
other cognitive domains, especially attention.
Conclusions: We conclude that the WRT is insufficient alone as a diagnostic tool for prodromal AD.Background
The term Mild Cognitive Impairment (MCI) describes a
group of individuals who are at an intermediate stage
between normal aging and dementia from clinical,
neurological, and neuropsychological standpoints. In
fact, individuals with MCI present with subjective mem-
ory complaints, corroborated by objective deficits on
mental status testing and standardized neuropsycho-
logical tests, without functional or social impairment
needed to diagnose dementia [1]. Prospective studies
show that these individuals are at an increased risk of
developing AD. Indeed, 10% to 15% of the individuals
with MCI will progress to dementia each year, compared
to an annual rate of 1% to 2% in the general population
over 65 years old [1]. Ultimately, in most memory
clinics, between 50% and 75% of patients presenting with
MCI will go on to dementia over long term follow-up
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distribution, and reproduction in any mediuma characteristic feature of Alzheimer’s disease (AD), to a
degree midway between that of normal individuals and
demented patients [4]. Recently, it has even been pro-
posed that MCI individuals with MRI atrophy or other
AD-like biomarkers, be considered as having prodromal
AD [5].
The existence of such a group of individuals at risk of
developing AD has encouraged research on diagnostic
tools that could discriminate those who will progress to
AD. Because of the demands of clinical settings, such
discriminative tests ought to be relatively inexpensive,
fairly quick to administer and opaque to other factors
that can affect cognitive functions such as depression
[6,7]. Memory loss being the core symptom of AD, re-
search has focused largely on neuropsychological tests
that assess this symptom. However, memory loss can be
easily confounded with encoding and attention deficits
seen in other conditions such as depression [8-10]. More
sophisticated memory tests may need to be administered
by neuropsychologists. At the same time, more studies
show that episodic memory deficits might not be the
only feature of mild AD [11]. For example, studies have
found subtle visuoperceptual deficits in AD, particularlyed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tests, being for less attention demanding, are likely to be
less influenced by depression – a major advantage for an
AD tests. One explanation of the deficits observed in
word-recognition tests could be the degeneration of the
“word-form area” in the occipital-temporal extrastriate
cortex [12] also affected, albeit to a lesser degree than
memory areas, in AD [13,14]. Another possible explan-
ation could be that patients with AD show poorer per-
formance on more demanding perceptual tasks because
they have slower central processing abilities. For in-
stance, a masked word recognition test is more demand-
ing on the central processing abilities than an unmasked
letter recognition test, and therefore, the former test
would be more sensitive in the earlier disease stages.
Based on these premises, our group conducted a
pilot study [15], testing the discriminative power of the
Word Reading Threshold (WRT) test. In brief, we used
a computerized test designed to assess visual percep-
tion changes encountered in AD or MCI. We found
that the mean WRT was significantly longer in the 13
patients with AD than in the 12 normal controls
(NC), and, with a threshold of 85 milliseconds (ms),
there was a diagnostic sensitivity of 77% and a diag-
nostic specificity of 92%. It was also found that all of
the four individuals with MCI who progressed to
dementia after two years of follow-up also scored
above that threshold. This test is inexpensive and sim-
ple to administer. These results therefore warranted
confirmation in a larger group of subjects in order to
test the specificity, reliability, and replicability of WRT,
as well as its opacity to other cognitive domains.
Consequently, the goal of this study is to validate the
WRT as a diagnostic tool in MCI individuals. More
precisely, we want to measure its sensitivity and speci-
ficity in a larger sample of AD, MCI and NC indivi-
duals, and examine potential cognitive correlates of
word recognition and prolonged WRT.
Methods
MCI and AD subjects were recruited from the memory
clinic of the Jewish General Hospital, a tertiary care re-
ferral centre at McGill University in Montreal, Canada.
The diagnostic criteria for AD were those suggested by
NINCDS-ADRDA [16]. The general criteria for a diag-
nosis of MCI utilized were 1) subjective memory com-
plaints, 2) corroborated by objective impairment on
neuropsychological tests compared to age and education
matched controls, 3) no functional or social impairment,
4) cognitive and functional impairment not sufficient to
meet criteria for dementia [17]. As part of the usual
evaluation at the clinic, each of the MCI and AD subjects
underwent a thorough physical and neurological examin-
ation to rule out other reversible causes of cognitivedecline, as well as extensive neuropsychological testing.
Normal elderly controls (NC) were recruited from the Fam-
ily Medicine Clinic of the Jewish General Hospital, from
advertisements in newspapers or conferences on memory
and from relatives of the MCI and AD subjects. They were
screened to exclude those with memory complaints, and
they underwent the same neuropsychological examination
as the other two groups. MCI individuals were followed at
the memory clinic about once a year for over 8 years to
monitor those who progressed (MCIp) and who did not
progress (MCInp). Table 1 summarizes the subjects’ demo-
graphics. All subjects signed a consent form and the study
was in compliance with the Helsinki Declaration and
approved by the Jewish General Hospital Research Ethic
Board.
Detailed procedures for the WRT assessment are
described in Massoud et al. [15]. In brief, four to six let-
ters nouns are presented on a computer screen, matched
across blocks for frequency. These nouns are presented
in blocks of ten words, each block with an increasing
presentation time. Forward and backward masking con-
sists of a series of number signs of the same size and
length as the target words. Subjects are asked to read
each word out loud. The percentage of the words in a
block that were correctly read is calculated. The WRT
score is defined as the presentation duration at which
50% of the words in a block are read correctly. Figure 1
depicts the presentation of the stimuli on the screen.
To calculate the sensitivity and the specificity of the
WRT at the suggested cut-off score of 85 ms, we com-
pared NC and AD patients as follow. Sensitivity is TP/
(TP + FN) and Specificity is TN/(TN + FP), where TP is
the number of true positives; FP, the number of false
positives; FN, the number of false negatives; and TN, the
number of true negatives. We also carried a Receiver-
Operating Characteristic (ROC) analysis to evaluate the
performance of WRT in classifying appropriately NC
and AD, and MCIp and MCInp.
Finally, to verify whether the WRT is opaque to other
cognitive domains, we correlated the WRT scores with
tests of memory, language and attention. We tested the
subjects on Logical Memory (LM) I and II subscales and
Visual Reproduction (VR) I and II subscales of the
Weschler Memory Scale-Revised (WMS-R [18]), Rey
Auditory-Verbal Learning Test (RAVLT [19]), Boston
Naming Test (BNT [20]), Controlled Word Association
Test (COWA [21]), the Trail Making Test, subscale A
(TRAIL [22]), and Stroop Test [23].
To determine group differences in WRT scores, one-
way ANOVA were performed, controlling for confound-
ing variables, such as the number of years of education
and depression scores on the Geriatric Depression Scale
(GDS). To specify which pair-groups were different,
Bonferroni’s post hoc analyses were performed. A difference
Table 1 Demographic and neuropsychological information
NC MCI AD
Mean (SD) Mean (SD) Mean (SD) AUC
N 33 60 29 122
EDUa, 13,8 (2,90) 11,2 (3,1) 11,9 (3,7) -
AGEa, b 74,7 (6,00) 75,0 (7,0) 78,1 (7,8) -
GDSa, b, c 3,4 (4,20) 6,7 (4,9) 7,4 (5,4) -
Duration - - 3,9 (3,2) 4,0 (2,2) -
MMSEa, b, c 29,0 (1,10) 27,1 (2,2) 22,9 (3,9) 0,48
WRTa, b, c 58,2 (24,10) 73,4 (25,7) 92,6 (31,7) 0,45
Memory
LM2a, b, c 12,7 (3,50) 5,8 (4,0) 1,5 (2,3) 0,82*
VR2 a, b, c 49,8 (19,30) 20,6 (17,5) 3,8 (7,5) 0,71
RAVLT delay a, b, c 8,6 (2,90) 3,2 (2,9) 0,4 (0,9) 0,76*
Language
COWA lexicala, b 49,0 (16,30) 32,8 (12,9) 25,8 (14,8) 0,51
COWA semantic a, b, c 17,9 (5,50) 13,0 (4,4) 7,4 (4,1) 0,48
BNT a, b, c 53,7 (7,00) 47,0 (8,7) 38,3 (11,0) 0,46
Attention
TRAIL a, b, c 41,5 (12,30) 52,8 (20,4) 68,3 (29,0) 0,45
STROOPda, b 14,7 (3,50) 16,9 (4,7) 24,4 (14,8) 0,49
STROOPwa, b 19,0 (4,70) 23,0 (5,8) 36,6 (33,8) 0,48
STROOPca, b 30,9 (6,80) 41,7 (11,4) 69,0 (44,2) 0,63
Numbers represent means (standard deviation). Age and EDU; education, are measured in number of years. NC stands for normal elderly controls; MCI, Mild
Cognitive Impairment; AD, Alzheiemer Disease; AUC, Area Under the Curve from ROC analyses on MCInp vs MCIp; GDS, Geriatric depression Scale; WRT, Word
Reading Threshold is in milliseconds; MMSE, Mini-Mental Status Examination; LM2, Logical Memory delayed; VR2, Visual Reproduction delayed; RAVLT delayed,
Rey-Auditory Verbal Learning Test delayed; TRAIL, Trail Making Test Subscale A; STROOPd, dots subscale of Stroop test; STROOPw, words subscale of Stroop Test;
STROOPc, colors subscale of Stroop Test. a, indicates significant difference between NC and MCI; b, indicates significant difference between NC and AD, c, indicates
significant difference between MCI and AD and * indicates significant AUC difference between MCInp and MCIp groups (p < 0.002).
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ler than 0.05. ROC analyses were performed on WRT and
other neuropsychological tests comparing NC and AD first,
and then comparing MCIp and MCInp. To assess the opa-
city of WRT to other cognitive functions, performances on
WRT were correlated with neuropsychological tests using
partial correlations to control for confounding variables
(education and depression), in the whole study sample first,
then in each diagnostic group. Bonferroni’s corrections for
multiple comparisons were applied to the partial correla-
tions and a p-value of 0.005 was used.Figure 1 Presentation of stimuli in word teading threshold test. Abov
actual time presentation of the items presented. Briefly, on a computer scr
milliseconds (ms), and is immediately followed by a mask, consisting of da
are presented at increasing duration. After a 3 ms time lapse, a backward m
followed by a question mark prompting a response from the participant. T
threshold for word recognition [15].Results
We collected WRT scores for 60 individuals with MCI,
29 patients with AD, and 33 NC. The three groups dif-
fered in terms of years of education (F(2,120) = 6.9, p =
0.001) and depression scores as measured by Geriatric
Depression Scale (GDS [24]: F(2,111) = 6.0, p = 0.003),
which correlated with WRT scores. Therefore, education
and GDS were entered as covariates in our analyses. Age
difference did not reach statistical significance.
We found significant differences in the groups’ per-
formance on WRT (F(2,119) = 12.7, p < 0.01). Bonferroni’se the arrow line is what is seen by the participant, and below is the
een, a dot announcing the presentation of a noun appears for 500
sh signs of same height and length as target noun, for 100 ms. Nouns
ask, consisting of the same dash signs is presented for 200 ms,
he target duration at which 5 out of 10 nouns are correctly read is the
Figure 3 ROC curves for individual tests in differentiating MCI
progressors from MCI non-progressors. Lines represent individual
ROC curves for individual tests in differentiating MCI who
progressed to AD from those who did not. WRT stands for Word
Reading Threshold is in milliseconds; LM2, Logical Memory delayed;
VR2, Visual Reproduction delayed; RAVLT delayed, Rey-Auditory
Verbal Learning Test delayed; COWA, Controlled-Word Association;
BNT, Boston Naming Test; TRAIL, Trail Making Test Subscale A;
STROOPd, dots subscale of Stroop test; STROOPw, words subscale of
Stroop Test; STROOPc, colors subscale of Stroop Test.
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existed between the three groups (p < 0.03). Figure 2 dis-
plays individual WRT scores in each group. Using the
cut-off determined in Massoud’s study (85 ms), we found
a diagnostic sensitivity of 72% and a specificity of 76%.
ROC analyses showed that WRT differentiate between
NC and AD about 81% of the time (p < 0.001). However,
the test does not perform better than chance alone at dif-
ferentiating MCIp and MCInp (Area Under the Curve,
AUC = 45%, p = 0.51). Indeed, WRT test correctly classi-
fied 6 out of the 19 MCI who had progressed to AD after
8 years of follow-up. Logical Memory (LM) delayed and
Ray Auditory Verbal Learning Test (RAVLT) delayed,
both tests assessing delayed verbal memory, were better
at discriminating between MCI subjects who progressed
(MCIp) and those who did not (MCInp). The AUC of
ROC analyses comparing the neuropsychological tests
between MCIp and MCInp are represented in Table 1
and Figure 3.
We found significant correlations, after Bonferroni’s
corrections for multiple comparisons, with memory as
measured with Visual Reproduction (VR) II (r = −0.32,
p = 0.003) and RAVLT delayed (r = −0.35, p = 0.001).
Scores on WRT also correlated with language tests scores,
as measured by Boston Naming Test (BNT; r = −0.32,
p = 0.002), Controlled Word Association (COWA)Figure 2 Individual word reading threshold scores in the three groups. Individual Word Reading Threshold (WRT) scores expressed in
milliseconds (ms) in normal elderly controls (NC), individuals with Mild Cognitive Impairment (MCI), and patients with Alzheimer’s disease (AD).
Dark circles indicate individuals who had progressed to AD or MCI at 8 years follow-up. Bar represents the cut-off proposed by Massoud et al.
(2002) above which scores should indicate potential progression from MCI to AD.
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est (r = −0.34, p = 0.001). However, these correlations
might have been spurious, as they did not remain sta-
tistically significant when the correlations were per-
formed in the diagnostic groups independently, with
the exception of COWA lexical subtest in the NC (p =
0.002). WRT was found to correlate with tests of atten-
tion, such as the Trail Making subscale A (TRAIL; r =
0.48, p < 0.001), Stroop dots (r = 0.39, p < 0.001). The
correlation between TRAIL and WRT remained
significant in NC (r = 0.623, p = 0.0002), whereas, in
the MCInp, the correlation was marginally significant
(p = 0.06). Also, one individual with AD had a TRAIL
score of 800 ms; that is, 5 standard deviations below
the average score of AD on that test. This poor
performance was not explained by visual impairment
and was therefore treated as an outlier. Taking that
subject out, revealed a significant positive correlation
(p = 0.0002). The correlation between STROOP dots
and WRT remained significant in the NC and MCInp.
Table 2 summarises the correlation coefficients for each
tests with WRT in each groups.Discussion
Similar to previous findings from this laboratory [15], we
found a significant difference in the WRT scores of the
AD compared to the MCI and NC groups. Even though
the WRT classified correctly NC and AD 81% of the
time, it showed lower diagnostic sensitivity (72%) and
specificity (76%) than previously found (77% and 92% re-
spectively). On average, the AD subjects included in our
study have shorter WRT and the MCI have somewhat
longer WRT than those in Massoud’s study (Massoud:Table 2 Correlations between WRT and
neuropsychological tests
NC MCIp MCInp AD
MMSE −0.44* −0.05 −0.26 −0.22 −0.57*
LM2 −0.25 −0.13 −0.03 −0.09 0.25
VR2 −0.32* −0.35 −0.01 −0.02 0.15
RAVLT delayed −0.35* −0.16 −0.17 −0.01 0.29
COWA lexical −0.35* −0.53* 0.00 −0.20 −0.04
COWA semantic −0.34* −0.39 0.20 −0.16 0.26
BNT −0.32* 0.05 0.01 −0.44 0.15
TRAIL 0.48* 0.62* 0.42† 0.02 0.66*
STROOP dot 0.39* 0.43* 0.48* −0.32 0.5
STROOP word 0.27 0.34 0.56* 0.08 −0.13
STROOP color 0.22 0.30 0.40 0.25 −0.20
These numbers represent pearson correlations. In the first column, are the
partial correlations of all the subjects, controlling for education and
depression. * marks significant correlations (p < 0.005) and † indicates a
marginal correlation (p = 0.006).MCI 60.3 ± 15.9 ms and AD 122.6 ± 70.8 ms; Present
study: MCI 73.4 ± 25.7 ms and AD 92.6 ± 31.7 ms).
It is worth noting that we found slightly bigger stand-
ard deviations in the NC and MCI groups, and smaller
ones in the AD group than what was previously
reported, indicating that our groups might have been
less homogenous. Examining the individuals scores from
Massoud’s study [15] and our own replication study
illustrates this difference clearly (Figure 2). In the pilot
study, only 1 out of 12 NC had a WRT score greater
than the 85 ms, compared to 8 out of 33 in our follow-
up study. Similarly, in Massoud’s study, only 3 out of 13
AD patients scored below the cut-off, compared with 8
out of 25 in the current study. We simply failed to main-
tain this striking separation between NC and AD
patients in a larger cohort. Even though the age and de-
mentia severity, measured by MMSE, of the groups were
similar in the two studies, we must conclude that the
pilot study, being smaller, simply showed less heterogen-
eity than was found in our replication study.
The ROC analyses showed that WRT does not per-
form better than chance level in classifying MCI indivi-
duals who will progress to AD or not (AUC = 0.45, p >
0.1). Indeed, in the current study, WRT only correctly
classified 32% of the MCI individuals who progressed to
dementia, which is less impressive than what Massoud
and his colleagues had found, where all of the MCI sub-
jects who had scored ≥ 85 ms on WRT had progressed
to AD after 2 years of follow-up. It is important to note
that the follow-up period in our study was of 8 years.
Massoud’s study included 4 individuals with MCI who
progressed to AD, which is within the expected pub-
lished rates of progression to AD (15% a year). The
current study, in contrast, yielded a larger sample of
converters. However, the average rate of progression
from MCI to AD in our study (about 4% a year) is lower
than in most studies [17]. In addition, examination of
the AUC for other neuropsychological tests reveals that
the delayed recall of Logical Memory and Ray Auditory
Verbal Learning Tests were better at discriminating
MCIp from MCInp (Table 1).
Massoud and colleagues found that WRT scores corre-
lated with scores on a global cognitive assessment test, the
MMSE. In our study, we replicated this finding, but we
wanted to evaluate whether WRT scores were related to
those of other cognitive tests. We found evidence for an
association between WRT scores and measures of memory
and language. These associations might be spurious, how-
ever, as they were found only when the three groups were
collapsed, with the exception of the lexical subtest of the
Controlled Word Association test in the NC group. WRT
scores were also correlated with measures of attention,
more precisely Trail Making Test A and Stroop dots subt-
est. This suggests that performance on WRT is related to
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we found that the association with Trail Making Test A
was maintained in the NC, MCInp, and AD groups, but
not in the MCIp group. Similarly, the association with
Stroop dots remained significant only in the NC and
MCInp groups. Although explaining the absence of correl-
ation in the MCIp or AD groups is beyond the scope of
this study, it might suggest that at the MCI stage of AD
pathology different cognitive domains are affected to dif-
ferent degrees. As for the absence of correlation between
MMSE and WRT scores in the NC and MCI groups, it
can easily be explained by ceiling effect. In the NC and
MCI groups, MMSE scores do not vary enough, whereas
in the AD group, MMSE scores range from 11 to 29.
Despite the fact that we selected the participants of
our study in the same way as Massoud and colleagues
did, MCI individuals whose WRT was greater than 85
ms were not more likely to progress to AD after 8 years
follow-up. This can be explained again by the larger
sample size. The original study was a small pilot study
and it is common for larger samples to lack the robust
separation found in smaller, more homogeneous sam-
ples. Without doubt, our larger sample introduced het-
erogeneity, as expressed in the increased standard
deviations in WRT scores of NC and MCI individuals.
The follow up period in our replication study was sig-
nificantly longer than in Massoud’s study, which brings
more support to the present findings. The participants
included in our replication study compared fairly well to
those of Massoud’s. They had similar education and
MMSE score, as well as similar duration of illness (this
study: 3.9 (0–15), Massoud’s study: 4.5 (2–10) for the
MCI and AD groups. The participants also compared
well in term of age and BNT scores.
Conclusions
As is the case with many studies that have looked for sim-
ple tests discriminating between MCI individuals who will
progress to AD and those who will not, the results are not
sufficiently robust to suggest WRT as a prognostic test.
Apart from obvious methodological differences in diag-
nosing MCI, these disappointing results might be
explained by the now established heterogeneity of AD and
the increasingly recognized heterogeneity of MCI. For ex-
ample, some patients with AD will show greater difficul-
ties with language or executive functions, whereas others
will show greater visuoperceptual deficits, this, aside from
the frequent comorbidity of other dementia [25,26]. This
heterogeneity of symptoms is also portrayed in the subdi-
visions of MCI; that is, pure amnestic MCI, multiple-
domains (including memory) MCI, single non-memory
domain MCI, and multiple non-memory domains MCI.
The use of a panel of simple neuropsychological tests, in
conjunction with imaging and possibly genetic biomarkersremains potentially more valuable in predicting progres-
sion to AD Petersen, [27].
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